IRVINE, Calif.--(BUSINESS WIRE)-- #Masimo--Masimo smartSET™-powered, AI-enabled OIRD detection has received FDA 510(k) clearance for the Radius VSM® wearable continuous patient monitor.

Masimo Corporation (MASI) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
while the company has successfully deleveraged its balance sheet to $485.9M in total debt, the forward P/E of 32.73 appears high given the historical volatility in net income and the ongoing integration risks of the consumer segment.
Masimo Corporation (MASI) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Masimo Corporation (MASI) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 5, 2026 | $1.43vs $1.41+1.4% | $400Mvs $399M+0.2% |
| Q1 2026 | Feb 26, 2026 | $0.18vs $1.48-87.8% | $413Mvs $408M+1.1% |
| Q4 2025 | Nov 4, 2025 | $1.32vs $1.19+10.9% | $372Mvs $408M-8.9% |
| Q3 2025 | Aug 5, 2025 | $1.33vs $1.23+8.1% | $371Mvs $369M+0.5% |
Recent stock market news and headlines for Masimo Corporation (MASI)
IRVINE, Calif.--(BUSINESS WIRE)-- #Masimo--Masimo smartSET™-powered, AI-enabled OIRD detection has received FDA 510(k) clearance for the Radius VSM® wearable continuous patient monitor.

Key metrics vs top competitors for Masimo Corporation (MASI)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $179.95 | $9.42B | -64.27 | -27.1% | -9.92% | -17.09% | — | |
| $161.55 | $11.34B | 46.42 | 30.73% | 10.44% | 21.38% | — | |
| $76.01 | $16.97B | 30.53 | 1.74% | 13.18% | 11.01% | — | |
| $17.72 | $2.02B | -14.52 | 8.28% | -25.66% | -50.82% | — | |
| $91.90 | $3.16B | 31.80 | 7.57% | 7.67% | 8.23% | — | |
| $155.37 | $3.88B | 5284.69 | -6.38% | 2.15% | 2.19% | — |
Masimo Corporation (MASI) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Masimo Corporation (MASI) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 4, 2026·SEC
Apr 23, 2026·SEC
Feb 17, 2026·SEC
Get notified when MASI posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Masimo Corporation (MASI) stock FAQ — growth, dividends, profitability & financials explained
Masimo Corporation (MASI) reported $1.56B in revenue for fiscal year 2025. This represents a 91576% increase from $1.7M in 1998.
Masimo Corporation (MASI) saw revenue decline by 27.1% over the past year.
Yes, Masimo Corporation (MASI) is profitable, generating $76.3M in net income for fiscal year 2025 (-9.9% net margin).
Masimo Corporation (MASI) has a return on equity (ROE) of -17.1%. Negative ROE indicates the company is unprofitable.
Masimo Corporation (MASI) generated $211.3M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.